Donanemab (Anti-Amyloid Beta)
A2833
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameDonanemab (Anti-Amyloid Beta)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionDonanemab (LY3002813) is a humanized IgG1 monoclonal antibody directed at an N-terminal pyroglutamate amyloid beta (Abeta) epitope. Donanemab has the potential for early Alzheimers disease research. MW : 145.36 KD.
- Storage Instruction-20°C
- UNSPSC12352203